Search

Your search keyword '"Lu, Karen H"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Lu, Karen H" Remove constraint Author: "Lu, Karen H" Publisher american society of clinical oncology (asco) Remove constraint Publisher: american society of clinical oncology (asco)
88 results on '"Lu, Karen H"'

Search Results

1. Normal Risk Ovarian Screening Study: 21-Year Update

2. Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis

3. Outcomes of the BRCA quality improvement dissemination program in three health systems.

4. A pilot phase II study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

6. EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer.

7. Results from MAGENTA: A national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk.

8. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline

9. Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations

10. An initiative to improve mortality index in gynecologic oncology.

14. Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers.

19. Active Disclosure of Secondary Germline Findings to Deceased Research Participants’ Personal Representatives: Process and Outcomes

20. Pathogenic variants in DNA damage response (DDR) genes in patients with advanced solid tumors.

21. Prospective randomized biomarker study of metformin and lifestyle intervention for prevention in obese postmenopausal women at increased risk for endometrial cancer.

24. Dissemination of universal genetic testing to three unique oncology care settings.

25. Prevalence of incidental germline pathogenic (PV) and likely pathogenic (LPV) variants in hereditary cancer-related genes identified in matched tumor/normal sequencing of advanced solid tumors.

28. Health4Families: An intervention to improve weight and health behaviors in families with hereditary breast/ovarian cancer or Lynch syndrome.

40. Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.

45. Symptoms of endometrial cancer.

48. Prevalence of incidental actionable germline mutations in 1,000 advanced cancer patients on a prospective somatic genomic profiling program.

49. Clinical characteristics and survival outcomes in BRCA1-methylated epithelial ovarian cancer (Bmeth-OC): A pooled analysis of data for 1,278 patients across five studies.

50. Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma

Catalog

Books, media, physical & digital resources